Pharma Journalist -

Portola Pharmaceuticals (PTLA) has expanded its existing clinical collaboration agreement with Daiichi Sankyo to develop AndexXa (andexanet alfa) as an antidote for the former’s Factor…
Read More...

Nimbus Therapeutics secured a $200m from Gilead Sciences in a payment related to the latter’s allosteric Acetyl-CoA Carboxylase (ACC) inhibitor program with NDI-010976 (now GS-0976)…
Read More...

Celgene and IBM Watson Health will co-develop a new offering that aims to enhance pharmacovigilance methods used to collect, assess, monitor, and report adverse drug reactions. The…
Read More...

Bosch Packaging Technology, a leading supplier of processing and packaging technology, expands its expertise in the non-aseptic packaging process for pharmaceuticals. Following the…
Read More...

The US Food and Drug Administration (FDA) has accepted for priority review Bristol-Myers Squibb's supplemental biologics license application (sBLA) for Opdivo (nivolumab) in previously…
Read More...

Virtus Pharmaceuticals has filed a lawsuit against the US Food and Drug Administration (FDA) and Department of Health and Human Services (HHS), seeking to prevent a monopoly, and…
Read More...

VBL Therapeutics has entered in to a long-term lease contract for a new stand-alone facility in Modiin, Israel. The site will house VBL's local biological drugs manufacturing facility,…
Read More...

IBM announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through…
Read More...

Nexus BioPharma has signed an agreement to license TransChem's transition state chemistry technology for kinase inhibition. Kinases are enzymes that regulate essential cellular…
Read More...

Codexis has completed the second and final phase in the transfer of its CodeEvolver protein engineering platform technology to Merck, known as MSD outside the US and Canada, under a…
Read More...